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Abstract
Aim: To evaluate the effect of low-protein diet on renal function in patient with diabetic nephropathy.
Materials and methods: This is a case of a 57-year-old obese patient who is a known case of type 2 diabetes,
hypertension, benign prostate hypertrophy and chronic kidney disease 4th stage presented with the complaints of
weakness, dyspnea, arthralgia, neuropathic pains and pedal edema which are prominent symptoms of Chronic kidney
disease. Our healthcare team had visited patient’s home and analyzed the available reports on kidney profile, fasting
sugar, post prandial sugar, HbA1c, lipid profile test and prescriptions which was found to be high. The glomerular
filtration rate, serum creatinine and blood urea were 24 ml/min, 3.4 mg/dL and 90 mg/dL, fasting blood sugar, post
prandial blood sugar and HbA1c were 226, 305 and 7.4 %, and total cholesterol and triglycerides were 145 &
95 respectively. Further discussion on diet, it came to know that the patient was on high carbohydrate diet.
By considering the objective and subjective data, our team had done the assessment and come to a conclusion that
high amount of carbohydrate diet with poor medication adherence had led to the hyperglycemia which developed
diabetic nephropathy. We have recommended low protein, unsaturated fat, multivitamins, antioxidants and moderate
carbohydrate diet. Two dietary assessment tools had been used in order to monitor patient’s adherence to the diet i.e.
dietary record book and food frequency questionnaire.
Results: We have carefully monitored the serum creatinine, glomerular filtration rate and blood urea for 12 months
initially with an interval of 30 days for 3 months and later trimonthly up-to 12 months. Glomerular filtration rate was
calculated by using the formula CKD-EPI creatinine equation. The values trend for first three months of serum
creatinine and glomerular filtration rate were 2.8 mg/dL, 2.6 mg/dL,1.5 mg/dL and 24 ml/min, 26 ml/min, 51 ml/
min respectively. Further, results has shown a significant improvement in the 6th, 9th and 12th month. The values
of serum creatinine in the 6th, 9th and 12th month were 1.3 mg/dL, 1.1 mg/dL and 0.9 mg/dL, whereas
golmerular filtration rate in the 6th, 9th and 12th month were 61 ml/min, 74 ml/min and 94 ml/min.
Conclusion: The present study has demonstrated the protein diet restriction in-order to control the progression
of renal failure. The dietary intervention on diabetic nephropathy plays a significant role in controlling the kidney
failures. This is the first study, to our knowledge, to demonstrate the impact of pharmacist role in managing diabetic
nephropathy by providing pharmaceutical care. Pharmaceutical care services should be encouraged in the community
and hospital pharmacy which definitely plays a major impact in reaching the definite outcomes and providing higher
quality of life.
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Background
The death and disability rate of chronic diseases have
exceeded than communicable diseases comprising 49 %.
In developing countries, the dominance of chronic dis-
eases is not well recognized by healthcare professionals.
The most common diseases are hypertension, angina,
stroke, diabetes, thyroid diseases and chronic kidney
disease [1].
According to international diabetes federation, India
has 40.9 million diabetic patients in the year-2006, 50.8
million in 2010, 60 million in 2014 and it is expected to
raise up-to 69.9 million by the year 2025. According to
the epidemiological study in India, Hyderabad is known
as diabetic capital of India with the prevalence of
16.6 % [2–5].
The dietary habits of Indians are 80 % carbohydrate
and low omega-3-fatty acids which may cause insulin
resistance leading to diabetic retinopathy, diabetic ne-
phropathy, diabetic neuropathy and macro-vascular
complications. Among them, diabetic nephropathy and
diabetic retinopathy are most common [6, 7].
Though there is uncertainty about the etiology of
kidney disease, heavy proteinuria is one the patho-
logical aspect in diabetic nephropathy. A Study shows
that restriction of protein helps to slow down the
progression of albuminuria, glomerular filtration rate
decline and occurrence of end stage renal disease [8].
Here, we discuss a patient with type 2 diabetes who
developed diabetes nephropathy. We report that low
protein diet in compliance with pharmaceutical care has
improved the glomerular filtration rate.
In this case, we have evaluated the effect of low-
protein diet on a patient with diabetic nephropathy
which was found to be effective.
Case presentation
This is a case of a 57-year-old obese patient who is a
known case of type 2 diabetes, hypertension, benign
prostate hypertrophy and chronic kidney disease 4th
stage presented with the complaints of weakness, dys-
pnea, arthralgia, neuropathic pains and pedal edema
which are prominent symptoms of chronic kidney dis-
ease. Our healthcare team had visited patient’s home
and analyzed the available reports on kidney profile,
fasting sugar, post prandial sugar, HbA1c, lipid profile
test and prescriptions which was found to be high.
The glomerular filtration rate, serum creatinine and
blood urea were 24 ml/min, 3.4 mg/dL and 90 mg/dL,
fasting blood sugar, post prandial blood sugar and HbAIc
were 226, 305 and 7.4 %, and total cholesterol and
triglycerides were 145 & 95 respectively.
The patient was on metoprolol 50 mg once daily,
amlodipine 5 mg once daily, telmisartan 40 mg once
daily, torsemide 10 mg once daily and prazosin 5 mg
once daily for managing blood pressure. His blood pres-
sure was optimized i.e. 123/78 mmHg, ruling out hyper-
tension as a cause for kidney damage. Ultra sonography
abdomen has revealed grade – 1 prostatomegaly for which
he was on tamsulosin 0.4 mg. Simultaneously he was
also using tramadol and acetaminophen combination
for arthralgia.
He was also using insulin 30 units, 15 units twice
daily and voglibose 0.2 mg for diabetes with improper
insulin storage. His lifestyle reveals that he consumes
high amount of carbohydrate without any physical activity.
By considering the objective and subjective data,
our team had done the assessment on the following
parameters:
Diet
The patient was on high carbohydrate diet which had
led to dramatic increase in glycemic values causing
diabetic nephropathy. Low protein, low potassium, low
phosphorous, moderate carbohydrates, and high fiber
diet have been recommended to the patient in order to
control the blood glucose levels and progression of
kidney failure. The dietary recommendations were based
on the international recommendations of glycemic index
and glycemic load [9].
We have also suggested a supplement which is rich in
L-carnitine, choline, molybdenum, chromium, selenium,
iodine, manganese, copper, zinc, iron, calcium, biotin,
pantothenic acid, folic acid, niacinamide, vitamin B12,
vitamin B6, vitamin B1, vitamin K, vitamin C, vitamin E,
vitamin A, vitamin D, low protein, taurine, glycine,
L-lysine, L-histidine and chloride which are essential
nutrients and multivitamins for a kidney patient.
The kidney disease outcome quality initiatives (K/
DOQI) nutrition guidelines suggest that a protein in-
take of 0.6 grams per kg of body weight may be benefi-
cial when glomerular filtration rate (GFR) drops below
25, or approximately 25 percent remaining kidney func-
tion [10]. Where-as the American diabetic association
suggests a, protein restriction of 0.8-1 g/kg/d may re-
tard the progression of nephropathy [11–13].
Based on his weight (88 kg), we have recommended
52.8 grams protein per day. Our team had given a diet
chart of low protein and moderate carbohydrate to the
patient in order to control the abnormal values of blood
glucose, serum creatinine and blood pressure.
Dietary assessment
Two dietary assessment tools had been used in order to
monitor patient’s adherence to the diet i.e. dietary record
book and food frequency questionnaire.
a. Dietary record book: day-wise dietary record book
was given to the patient to monitor the dietary
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habits. Dietary record book was monitored bi-weekly
by the pharmacist. Upon every visit, our pharmacist
counselled and motivated the patient for better dietary
adherence. Pharmacist also calculated the protein
intake to make sure that it should not exceed
than the recommended range.
b. Food frequency questionnaire: Food frequency
questionnaire (FFQ) has been evaluated every
week in order to determine the highest and the
lowest frequency of food items. Based on FFQ,
dietary corrections had been made in accordance
with glycemic index and glycemic load.
Analgesics
Avoid oral analgesics as it may further damage the
kidney function. We recommended him to use topical
non-steroidal anti-inflammatory drugs instead of oral
non-steroidal anti-inflammatory drugs.
Storage of insulin
The patient was not aware of the fact that the insulin
should be stored between 2 to 6 degrees which was get-
ting saturated. We counselled him on proper storage of
insulin.
Brisk walking
We recommended him to do brisk walking regularly for
20 – 30 minutes every day.
Result
Initially for 3 consecutive months with an interval of
30 days, we have monitored the laboratory values and
diabetic diet. Later, patient was monitored trimonthly
up-to 1 year. Glomerular filtration rate was calculated by
using the formula CKD-EPI creatinine equation. The
values trend for first three months of serum creatinine
and glomerular filtration rate were 2.8 mg/dL, 2.6 mg/
dL,1.5 mg/dL and 24 ml/min, 26 ml/min, 51 ml/min re-
spectively. Further, results has shown a significant im-
provement in the 6th, 9th and 12th month. The values
of serum creatinine in the 6th, 9th and 12th month were
1.3 mg/dL, 1.1 mg/dL and 0.9 mg/dL, whereas golmeru-
lar filtration rate in the 6th, 9th and 12th month were 61
ml/min, 74 ml/min and 94 ml/min. which can be shown
in Table 1.
The dietary habits was also been monitored by
pharmacist personal visits. The diet was been assessed
by using two dietary assessment tools such as dietary re-
cords and food frequency questionnaire. The objective
of this assessment tools is to provide the diet with low
protein and low to medium glycemic load and glycemic
index.
Day-wise record book has been given to the patient in
order to monitor the diet. Food frequency questionnaire
(FFQ) has been evaluated every week in order to deter-
mine the highest and the lowest frequency of food items.
Based on FFQ, dietary corrections had been made in ac-
cordance with glycemic index and glycemic load.
Discussion
According to Hepler and Strand, pharmaceutical care is
defined as “the responsible provision of medicine ther-
apy for the purpose of a definite outcome that improves
a patient’s quality of life” [14]. The concept of pharma-
ceutical care plan is to form the bridge between patient
and physician by the pharmacist. Pharmaceutical care
plan involves active co-ordination of the physician, pa-
tient and the pharmacist. The main challenge for the
pharmacist is to record the subjective and objective data,
to understand the chronic condition of the patient, to
counsel him on the lifestyle and diet and if necessary,
recommendation to physicians with an appropriate evi-
dence based literature.
In this case, due to in-science the patient was follow-
ing high carbohydrate and low omega-3 fatty acid diet.
This composition is present in all the meals throughout
the day. Both high carbohydrate and low omega-3 fatty
acid lead to diabetic complications diet. Later, patient
developed the microvascular complication of diabetes
that is diabetic nephropathy.
According to a systemic review conducted by Salgado
TM, pharmacist played an important role in achieving
the quality outcomes in patients with chronic kidney dis-
ease by reducing all-cause hospitalizations, incidence of
end stage renal disease or deaths with diabetic nephrop-
athy and managing anemia, blood pressure, lipid profile
Table 1 Laboratory reports after pharmaceutical care
Parameter 1st month 2nd month 3rd month 6th month 9th month 12th month
Fasting blood sugar 108 mg/dl 90 mg/dl 73 mg/dl 84 mg/dl 92 mg/dl 89 mg/dl
Post prandial blood sugar 258 mg/dl 190 mg/dl 156 mg/dl 151 mg/dl 145 mg/dl 141 mg/dl
HbA1c 7.2 % 6.8 % 6.5 % 6.3 % 6.4 % 6.5 %
Serum creatinine 2.8 mg/dl 2.6 mg/dl 1.5 mg/dl 1.3 mg/dl 1.1 mg/dl 0.9 mg/dl
Blood urea 78 mg/dl 45.6 mg/dl 39 mg/dl 34 mg/dl 29 mg/dl 27 mg/dl
Glomerular filtration rate 24 ml/min 26 ml/min 51 ml/min 61 ml/min 74 ml/min 94 ml/min
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etc. In our patient, we have not only reduced the inci-
dence of hospitalization, end stage renal disease but also
managed other health care parameters like diabetes,
blood pressure and cholesterol [15].
Unfortunately Indian community pharmacies are
only involved in dispensing the medicines. Complete
knowledge of drug-drug interactions, dose based on
patient biochemical data and fed-fast variability of
drug bioavailability would help both patient and phys-
ician. But, community pharmacy has a great oppor-
tunity to improve the health-care among the community
population. However, the pharmacist’s role in India is
expected to standardize the pharmacy settings which
not only sells the medicines but also provides the
services.
Nowadays, pharmaceutical care has become a dom-
inant form of practice for thousands of pharmacists
all over the world. However, for the patients and
pharmacists in India, this concept remains unknown
because it is not being performed as a routine, and
pharmacists especially community pharmacists are not
aware of the same. It is important to emphasize the
fact that pharmaceutical care is aimed to achieve ra-
tional and evidence-based pharmacotherapy, which is
beneficial for patient and society.
This case study is a testimony of critical role of
pharmacist in patient care. Our team suggested rele-
vant diet to the patient that improved the clinical sta-
tus of patient by reducing the biomarkers such as
serum creatinine and blood urea.
According to tumkur et.al, Indian pharmacists’ are
underutilized in the management of patient’s health.
In India, patients’ therapy is only managed by phys-
ician with the help of nurses which doesn’t give an
opportunity to the pharmacist. But, pharmacist has a
very vast role in managing patients’ health. Retail
pharmacy is best suited to provide the individualized
patient care by providing patient counseling, review-
ing of prescriptions, detection of potential side ef-
fects, etc.
Unfortunately, Indian pharmacy education is more in-
dustrial than clinical, which requires the Indian amend-
ment to include the concept of pharmaceutical care in
various communities [16].
Conclusion
The present study has demonstrated the protein diet
restriction in-order to control the progression of renal
failure. The dietary intervention on diabetic nephropa-
thy plays a significant role in controlling the kidney
failures. This is the first study, to our knowledge, to
demonstrate the impact of pharmacist role in managing
diabetic nephropathy by providing pharmaceutical care.
Pharmaceutical care services should be encouraged in
the community and hospital pharmacy which definitely
plays a major impact in reaching the definite outcomes
and providing higher quality of life. There is a vast
scope for pharmaceutical care and future studies should
be carried out to determine its impact. Knowledge of
pharmaceutical care should be reached out to patients’
as well as physicians, in order to bridge the gap be-
tween them. However, it would be necessary to con-
tinue evaluating kidney function in more subjects in
order to confirm whether the positive effect of the
present intervention can be sustained.
My health pharmacy is the first organized retail
chain in India which has introduced the concept of
pharmaceutical care in managing the patients’ health.
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